Protecting against vascular disease in brain

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 5, 2011, Pages

  Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Angiotensin II; Cardiovascular risk factors; Cerebral blood flow; Endothelium; Nitric oxide; Oxidative stress; Peroxisome proliferator activated receptor

Indexed keywords

2,4 THIAZOLIDINEDIONE; ANGIOTENSIN II; ANTIOXIDANT; DIMETHYLARGININASE; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PIOGLITAZONE; RECOMBINANT INTERLEUKIN 10; ROSIGLITAZONE;

ALZHEIMER DISEASE; BRAIN BLOOD VESSEL; BRAIN PROTECTION; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; DEMENTIA; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASCULAR BIOLOGY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULITIS;

BRAIN DISEASES; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; OXIDATIVE STRESS; VASCULAR DISEASES;

EID: 79955770689     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01310.2010     Document Type: Review

References (300)

1. Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 37: 13-25, 2010.
2. Agarwal R, Campbell RC, Warnock DG. Oxidative stress in hypertension and chronic kidney disease: role of Ang II. Semin Nephrol 24: 101-114, 2004.
3. Ahmed E, Hamel E. Muscarinic-but not nicotinic-acetylcholine receptors mediate a nitric oxide-dependent dilation in brain cortical arterioles: a possible role for the M5 receptor subtype. J Cereb Blood Flow Metab 20: 298-305, 2000.
4. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 324: 1098-1104, 1991.
5. Alexis JD, Wang N, Che W, Lerner-Marmarosh N, Sahni A, Korshunov VA, Zou Y, Ding B, Yan C, Berk BC, Abe J. Bcr kinase activation by angiotensin II inhibits peroxisome proliferator-activated receptor γ transcriptional activity in vascular smooth muscle cells. Circ Res 104: 69-78, 2009.
6. Al-Shali KZ, House AA, Hanley AJG, Khan HMR, Harris SB, Zinman B, Mamakeesick M, Fenster A, Spence JD, Hegele RA. Genetic variation in PPARG encoding peroxisome proliferator-activated receptor γ associated with carotid atherosclerosis. Stroke 35: 2036-2040, 2004.
7. Ando H, Zhou J, Macova M, Imboden H, Saavedra JM. Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. Stroke 35: 1726-1731, 2004.
8. Andresen JJ, Shafi NI, Bryan RM. Endothelial influences on cerebrovascular tone. J Appl Physiol 100: 318-327, 2006.
9. Arai K, Lo EH. An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J Neurosci 29: 4351-4355, 2009.
10. Arrick DM, Sharp GM, Sun H, Mayhan WG. Diabetes-induced cerebrovascular dysfunction: role of poly(ADP-ribose) polymerase. Microvasc Res 73: 1-6, 2007.
11. Arrick DM, Sharp GM, Sun H, Mayhan WG. Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats. Brain Res 1209: 128-135, 2008.
12. Arrick DM, Mayhan WG. Acute infusion of nicotine impairs nNOSdependent reactivity of cerebral arterioles via an increase in oxidative stress. J Appl Physiol 103: 2062-2067, 2007.
13. Arrick DM, Mayhan WG. Inhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic rats. Microcirculation 17: 439-446, 2010.
14. Arrick DM, Sharpe GM, Sun H, Mayhan WG. nNOS-dependent reactivity of cerebral arterioles in Type 1 diabetes. Brain Res 1184: 365-371, 2007.
15. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-a review of a new approach. Pharmacol Rev 55: 241-269, 2003.
16. Attwell D, Buchan AM, Charpak S, Lauritzen M, MacVicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature 468: 232-243, 2010.
17. Austin SA, Santhanam AV, Katusic ZS. Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ Res 107: 1498-1502, 2010.
18. Baranov D, Armstead WM. Selective blockade of AT1 receptor attenuates impairment of hypotensive autoregulation and improves cerebral blood flow after brain injury in the newborn pig. Anesthesiology 99: 1118-1124, 2003.
19. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402: 880-883, 1999.
20. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 13: 968-972, 1989.
21. Baumbach GL, Sigmund CD, Bottiglieri T, Lentz SR. Structure of cerebral arterioles in cystathione β-synthase deficient mice. Circ Res 91: 931-937, 2002.
22. Baumbach GL, Sigmund CD, Didion SP, Faraci FM. Hypertrophy of cerebral arterioles in mice deficient in expression of the gene for CuZn superoxide dismutase. Stroke 37: 1850-1855, 2006.
23. Baumbach GL, Sigmund CD, Faraci FM. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension 41: 50-55, 2003.
24. Baumbach GL, Sigmund CD, Faraci FM. Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase. Circ Res 95: 822-829, 2004.
25. Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med 2: 247-257, 2010.
26. Beyer AM, Baumbach GL, Halabi CM, Modrick ML, Lynch CM, Gerhold TD, Ghoneim SM, de Lange W, Keen HL, Tsai YS, Maeda N, Sigmund CD, Faraci FM. Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. Hypertension 51: 867-871, 2008.
27. Beyer AM, de Lange WJ, Halabi CM, Modrick ML, Keen HL, Faraci FM, Sigmund CD. Endothelium-specific interference with PPARγ causes cerebral vascular dysfunction in response to a high fat diet. Circ Res 103: 654-661, 2008.
28. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, Smieja M, Cambien F, Meyer J, Lackner KJ. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349: 1605-1613, 2003.
29. Boger RH. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 38: 126-136, 2006.
30. Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadski C, Jude B, Torpler G, Marx N, Staels B, Chinetti- Gbaguidi G. PPARγ activation primes human monocytes into alternative M2 monocytes with anti-inflammatory properties. Cell Metab 6: 137-143, 2007.
31. Brasier AR. The nuclear factor-κB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86: 211-218, 2010.
32. Brown KA, Didion SP, Andresen JJ, Faraci FM. Effect of aging, MnSOD deficiency, and genetic background on endothelial function: evidence for MnSOD haploinsufficiency. Arterioscler Thromb Vasc Biol 27: 1941-1946, 2007.
33. Bryan RM Jr, You J, Golding EM, Marrelli SP. Endothelium-derived hyperpolarizing factor: a cousin to nitric oxide and prostacyclin. Anesthesiology 102: 1261-1277, 2005.
34. Budzyn K, Marley PD, Sobey CG. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. Trends Pharmacol Sci 27: 97-104, 2006.
35. Butt AM, Jones HC, Abbott NJ. Electrical resistance across the blood-brain barrier in anesthetized rats: a developmental study. J Physiol 429: 47-62, 1990.
36. Caligiuri G, Rudling M, Ollivier V, Jacob MP, Michel JB, Hansson GK, Nicoletti A. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 9: 10-17, 2003.
37. Capone C, Anrather J, Milner TA, Iadecola C. Estrous cycle-dependent neurovascular dysfunction induced by angiotensin II in the mouse neocortex. Hypertension 54: 302-307, 2009.
38. Capone C, Faraco G, Anrather J, Zhou P, Iadecola C. Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II. Hypertension 55: 911-917, 2010.
39. Capone C, Faraco G, Park L, Cao X, Davisson RL, Iadecola C. The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. Am J Physiol Heart Circ Physiol 300: H397-H407, 2011.
40. Cardounel AJ, Cui H, Samouilov A, Johnson W, Kearns P, Tsai AL, Berka V, Zweier JL. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem 282: 879-887, 2007.
41. Cattaruzza M, Slodowski W, Stojakovic M, Krzesz R, Hecker M. Interleukin-10 induction of nitric-oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells. J Biol Chem 278: 37874-37880, 2003.
42. Chan SL, Baumbach GL. Nox2 deficiency prevents angiotensin IIinduced hypertrophy and inward remodeling in cerebral arterioles (Abstract). FASEB J 23: 613.11, 2009.
43. Charpie JR, Schreur KD, Papadopoulos SM, Webb RC. Acetylcholine induces contraction in vertebral arteries from treated hypertensive patients. Clin Exp Hypertens 18: 87-99, 1996.
44. Chen J, Zacharek A, Zhang C, Jiang H, Li Y, Roberts C, Lu M, Kapke A, Chopp M. Endothelial nitric oxide synthase regulates brainderived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci 25: 2366-2375, 2005.
45. Chen S, Li G, Zhang W, Wang J, Sigmund CD, Olson JE, Chen Y. Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice. Am J Physiol Regul Integr Comp Physiol 297: R1526-R1531, 2009.
46. Cho DH, Choi YJ, Jo SA, Jo I. Nitric oxide production and regulation of endothelial nitric oxide synthase phosphorylation by prolonged treatment with troglitizone: evidence for involvement of peroxisome proliferator- activated receptor (PPAR) gamma-dependent and PPAR gammaindependent signaling pathways. J Biol Chem 279: 2499-2506, 2004.
47. Chrissobolis S, Didion SP, Kinzenbaw DA, Schrader LI, Dayal S, Lentz SR, Faraci FM. Glutathione peroxidase plays a major role in protecting against angiotensin II-induced vascular dysfunction. Hypertension 51: 872-877, 2008.
48. Chrissobolis S, Faraci FM. The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol Med 14: 495-502, 2008.
49. Chrissobolis S, Faraci FM. Sex differences in protection against angiotensin II-induced endothelial dysfunction by manganese superoxide dismutase in the cerebral circulation. Hypertension 55: 905-910, 2010.
50. Chrissobolis S, Zhang Z, Kinzenbaw DA, Lynch CM, Russo AF, Faraci FM. Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction. Stroke 41: 2329-2334, 2010.
51. Cipolla MJ. The cerebral circulation. In: Integrated Systems Physiology: From Molecule to Function, edited by Granger DN, Granger J. San Rafael, CA: Morgan & Claypool Life Sciences, 2010, p. 1-59.
52. Cipolla MJ, Bishop N, Vinke RS, Godfrey JA. PPARγ activation prevents hypertensive remodeling of cerebral arteries and improves vascular function in female rats. Stroke 41: 1266-1270, 2010.
53. Cipolla MJ, Bullinger LV. Reactivity of brain parenchymal arterioles after ischemia and reperfusion. Microcirculation 15: 495-501, 2008.
54. Cipolla MJ, Smith J, Kohlmeyer MM, Godfrey JA. SKCa and IKCa channels, myogenic tone, and vasodilator responses in middle cerebral arteries and parenchymal arterioles: effect of ischemia and reperfusion. Stroke 40: 1451-1457, 2009.
55. Cipolla MJ, Sweet JG, Chan SL. Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J Appl Physiol 110: 329-339, 2011.
56. Crowley RW, Medel R, Kassell NF, Dumont AS. New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage. Drug Discov Today 13: 254-260, 2007.
57. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Inflammation and endothelial dysfunction during aging: role of NF-κB. J Appl Physiol 105: 1333-1341, 2008.
58. Dai X, Faber JE. Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis. Circ Res 106: 1870-1881, 2010.
59. Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1a receptor. Circulation 110: 3849-3857, 2004.
60. Dayal S, Arning E, Bottiglieri T, Boger RH, Sigmund CD, Faraci FM, Lentz SR. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke 35: 1957-1962, 2004.
61. Dayal S, Devlin AM, McCaw RB, Liu ML, Arning E, Bottiglieri T, Shane B, Faraci FM, Lentz SR. Cerebral vascular dysfunction in methionine synthase-deficient mice. Circulation 112: 737-744, 2005.
62. Dayoub H, Radionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, Lentz SR, Faraci FM. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation. Stroke 39: 180-184, 2008.
63. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK. Nitric oxide decreases cytokineinduced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96: 60-68, 1995.
64. de Groot E, van Leuven SI, Duivenvoorden R, Meuwese MC, Akdim F, Bots ML, Kastelein JJ. Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Rev Cardiol 5: 280-288, 2008.
65. De Silva TM, Broughton BR, Drummond GR, Sobey CG, Miller AA. Gender influences cerebral vascular responses to angiotensin II through Nox2-derived reactive oxygen species. Stroke 40: 1091-1097, 2009.
66. Didion SP, Faraci FM. Ceramide-induced impairment of endothelial function is prevented by CuZn superoxide dismutase overexpression. Arterioscler Thromb Vasc Biol 25: 90-95, 2005.
67. Didion SP, Hathaway CA, Faraci FM. Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD. Am J Physiol Heart Circ Physiol 281: H1697-H1703, 2001.
68. Didion SP, Heistad DD, Faraci FM. Mechanisms that produce nitric oxide-mediated relaxation of cerebral arteries during atherosclerosis. Stroke 32: 761-766, 2001.
69. Didion SP, Kinzenbaw DA, Faraci FM. Genetically-altered mice reveal a critical role for CuZnSOD in preventing angiotensin-II-induced endothelial dysfunction. Hypertension 46: 1147-1153, 2005.
70. Didion SP, Kinzenbaw DA, Fegan PR, Didion LA, Faraci FM. Overexpression of CuZn-SOD prevents lipopolysaccharide-induced endothelial dysfunction. Stroke 35: 1963-1967, 2004.
71. Didion SP, Kinzenbaw DA, Schrader LI, Faraci FM. Heterozygous CuZn superoxide dismutase deficiency produces a vascular phenotype with aging. Hypertension 48: 1072-1079, 2006.
72. Didion SP, Kinzenbaw DA, Schrader LI, Chu Y, Faraci FM. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension 54: 619-624, 2009.
73. Didion SP, Lynch C, Baumbach GL, Faraci FM. Impaired endothelium- dependent responses and enhanced influence of rho-kinase in cerebral arterioles in type II diabetes. Stroke 36: 342-347, 2005.
74. Didion SP, Ryan MJ, Baumbach GL, Sigmund CD, Faraci FM. Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen. Am J Physiol Heart Circ Physiol 283: H1569-H1576, 2002.
75. Didion SP, Ryan MJ, Didion LA, Fegan PE, Sigmund CD, Faraci FM. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res 91: 938-944, 2002.
76. Didion SP, Sigmund CD, Faraci FM. Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. Stroke 31: 760-764, 2000.
77. Diep QN, El Mabrouk M, Cohn JS, Endemann D, Amiri F, Virdis A, Neves MF, Schiffrin EL. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-γ. Circulation 105: 2296-302, 2002.
78. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG, Dikalov SI. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 107: 106-116, 2010.
79. d'Uscio LV, Smith LA, Katusic ZS. Erythropoietin increases expression and function of vascular copper- and zinc-containing superoxide dismutase. Hypertension 55: 998-1004, 2010.
80. d'Uscio LV, Smith LA, Santhanam AV, Richardson D, Nath KA, Katusic ZS. Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension 49: 1142-1148, 2007.
81. + channels. Circ Res 104: 987-994, 2009.
82. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)- CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95: 8880-8885, 1998.
83. Edvinsson L. Cerebrovascular angiotensin AT1 receptor regulation in cerebral ischemia. Trends Cardiovasc Med 18: 98-103, 2008.
84. Edvinsson L, Krause D. Cerebral Blood Flow and Metabolism (2nd ed.). Philadelphia, PA: Lippincott Williams & Wilkins, 2001.
85. Erdos B, Snipes JA, Miller AW, Busija DW. Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes 53: 1352-1359, 2004.
86. Erdos B, Snipes JA, Tulbert CD, Katakam P, Miller AW, Busija DW. Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production. Am J Physiol Heart Circ Physiol 290: H1264-H1270, 2006.
87. Fang Q, Sun H, Mayhan WG. Impairment of nitric oxide synthasedependent dilatation of cerebral arterioles during infusion of nicotine. Am J Physiol Heart Circ Physiol 284: H528-H534, 2003.
88. Faraci FM. Hydrogen peroxide: watery fuel for change in vascular biology. Arterioscler Thromb Vasc Biol 26: 1931-1933, 2006.
89. Faraci FM. Protecting the brain with eNOS: run for your life. Circ Res 99: 1029-1030, 2006.
90. Faraci FM. Reactive oxygen species: influence on cerebral vascular tone. J Appl Physiol 100: 739-743, 2006.
91. Faraci FM, Brian JE, Heistad DD. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol Heart Circ Physiol 269: H1522-H1527, 1995.
92. Faraci FM, Didion SP. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24: 1367-1373, 2004.
93. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 66: 8-17, 1990.
94. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78: 53-97, 1998.
95. Faraci FM, Lamping KG, Modrick ML, Ryan MJ, Sigmund CD, Didion SP. Cerebral vascular effects of angiotensin II: new insights from genetic models. J Cereb Blood Flow Metab 26: 449-455, 2006.
96. Faraci FM, Modrick ML, Lynch CM, Didion LA, Fegan PE, Didion SP. Selective cerebral vascular dysfunction in Mn-SOD-deficient mice. J Appl Physiol 100: 2089-2093, 2006.
97. Faraci FM, Modrick ML, Lynch CM, Pelham CJ, Ketsawatsomkron P, Sigmund CD. Vasodilation to nitric oxide is markedly impaired following selective interference with PPARγ in vascular muscle (Abstract). Stroke 42: e42, 2011.
98. Faraci FM, Sigmund CD, Shesely EG, Maeda N, Heistad DD. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol Heart Circ Physiol 274: H564-H570, 1998.
99. Feletou M, Kohler R, Vanhoutte PM. Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr Hypertens Rep 12: 267-275, 2010.
100. Flammer AJ, Luscher TF. Three decades of endothelium research. From the detection of nitric oxide to the everyday implementation of endothelial function measurements in cardiovascular disease. Swiss Med Wkly 140: w13122, 2010.
101. Fleegal-DeMotta MA, Doghu S, Banks WA. Angiotensin II modulates BBB permeability via activation of the AT1 receptor in brain endothelial cells. J Cereb Blood Flow Metab 29: 640-647, 2009.
102. Francis SH, Busch JL, Corbin JD. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 62: 525-563, 2010.
103. Fujii K, Heistad DD, Faraci FM. Flow-mediated dilatation of the basilar artery in vivo. Circ Res 69: 697-705, 1991.
104. Garthwaite G, Bartus K, Malcolm D, Goodwin D, Kollb-Sielecka M, Dooldeniya C, Garthwaite J. Signaling from blood vessels to CNS axons through nitric oxide. J Neurosci 26: 7730-7740, 2006.
105. Geddawy A, Shimosato T, Tawa M, Imamura T, Okamura T. Comparison of endothelium-related responses to nucleotides of dog and monkey cerebral arteries. J Pharmacol Sci 112: 378-381, 2010.
106. 2+ channel activity in angiotensin-hypertension. Hypertension 41: 1124-1130, 2003.
107. Girouard H, Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 100: 328-335, 2006.
108. Girouard H, Lessard A, Capone C, Milner TA, Iadecola C. The neurovascular dysfunction induced by angiotensin II in the mouse neocortex is sexually dimorphic. Am J Physiol Heart Circ Physiol 294: H156-H163, 2008.
109. Girouard H, Park L, Anrather J, Zhou P, Iadecola C. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through Nox-2-derived radicals. Arterioscler Thromb Vasc Biol 26: 826-832, 2006.
110. Girouard H, Park L, Anrather J, Zhou P, Iadecola C. Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II. Arterioscler Thromb Vasc Biol 27: 303-309, 2007.
111. Golding EM, You J, Robertson CS, Bryan RM Jr. Potentiated endothelium- derived hyperpolarizing factor-mediated dilations in cerebral arteries following mild head injury. J Neurotrauma 18: 691-697, 2001.
112. Gunnett CA, Berg DJ, Faraci FM. Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke 30: 2191-2196, 1999.
113. Gunnett CA, Heistad DD, Berg DJ, Faraci FM. Interleukin-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am J Physiol Heart Circ Physiol 279: H1555-H1562, 2000.
114. Gunnett CA, Heistad DD, Faraci FM. Interleukin-10 protects endothelium- dependent relaxation during diabetes: role of superoxide. Diabetes 51: 1931-1937, 2002.
115. Halabi CM, Beyer AM, de Lange WJ, Keen HL, Baumbach GL, Faraci FM, Sigmund CD. Interference with PPARγ in smooth muscle causes vascular dysfunction and hypertension. Cell Metab 7: 215-226, 2008.
116. Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KRA, Quyyumi AA. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106: 653-658, 2002.
117. Hamel E. Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol 100: 1059-1064, 2006.
118. Harper SL, Bohlen HG. Microvascular adaptation in the cerebral cortex of adult spontaneously hypertensive rats. Hypertension 6: 408-419, 1984.
119. Harper SL, Bohlen HG, Rubin MJ. Arterial and microvascular contributions to cerebral cortical autoregulaton in rats. Am J Physiol Heart Circ Physiol 246: H17-H24, 1984.
120. Harrison DG, Guzik TJ, Lob H, Madhur M, Marvar PJ, Thabet S, Vinh A, Weyand C. Inflammation, immunity, hypertension. Hypertension 57: 132-140, 2011.
121. Hatake K, Kakishita E, Wakabayashi I, Sakiyama N, Hishida S. Effect of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke 21: 1039-1043, 1990.
122. Heagerty AM. Predicting hypertension complications from small artery structure. J Hypertens 25: 939-940, 2007.
123. Heikkinen S, Auerx J, Argmann CA. PPARγ in human and mouse physiology. Biochim Biophys Acta 1771: 999-1013, 2007.
124. Hernanz R, Briones AM, Alonso MJ, Vila E, Salaices M. Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin impairment after LPS in rat cerebral arteries. Am J Physiol Heart Circ Physiol 287: H225-H234, 2004.
125. Herse F, Staff AC, Hering L, Muller DN, Luft FC, Dechend R. AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia. J Mol Med 86: 697-703, 2008.
126. Hiroi Y, Kim HH, Ying H, Furuya F, Huang Z, Simoncini T, Noma K, Ueki K, Nguyen NH, Scanlan TS, Moskowitz MA, Cheng SY, Liao JK. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 103: 14104-14109, 2006.
127. Hossmann KA. Variability thresholds and the penumbra of focal ischemia. Ann Neurol 36: 557-565, 1994.
128. Hwang J, Kleinhenz DJ, Rupnow HL, Campbell AG, Thule PM, Sutliff RL, Hart CM. The PPAR ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice. Vascul Pharmacol 46: 456-462, 2007.
129. Iida H, Iida M, Takenaka M, Fujiwara H, Dohi S. Angiotensin type 1 (AT1)-receptor blocker prevents impairment of endothelium-dependent cerebral vasodilation by acute cigarette smoking in rats. Life Sci 78: 1310-1316, 2006.
130. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 120: 287-296, 2010.
131. Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab 7: 476-484, 2008.
132. Iadecola C, Nedergaard M. Glia regulation of the cerebral microvasculature. Nat Neurosci 10: 1369-1376, 2007.
133. Iadecola C, Yang G, Ebner TJ, Chen G. Local and propagated vascular responses evoked by focal synaptic activity in cerebellar cortex. J Neurophysiol 78: 651-659, 1997.
134. Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fisher E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 2: 157-161, 1999.
135. 2+- superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50: 3-11, 2001.
136. Ishikawa M, Stokes KY, Zhang JH, Nanda A, Granger DN. Cerebral microvascular responses to hypercholesterolemia. Roles of NADPH oxidase and P-selectin. Circ Res 94: 239-244, 2004.
137. Ito T, Yamakawa H, Bregonzio C, Terron JA, Falcon-Neri A, Saavedra JM. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke 33: 2297-2303, 2002.
138. Iuliano BA, Pluta RM, Jung C, Oldfield EH. Endothelial dysfunction in a primate model of cerebral vasospasm. J Neurosurg 100: 287-294, 2004.
139. Jagtop P, Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4: 421-440, 2005.
140. Jones A, Deb R, Torsney E, Howe F, Dunkley M, Gnaneswaran Y, Gaze D, Nasr H, Loftus IM. Rosiglitazone reduces the development and rupture of experimental aortic aneurysm. Circulation 119: 3125-3132, 2009.
141. Joutel A, Monet-Lepretre M, Gosele C, Baron-Menguy C, Hammes A, Schmidt S, Lemaire-Carrett B, Domenga V, Schedl A, Lacombe P, Hubner N. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest 120: 433-445, 2010.
142. Kaito N, Onoue H, Abe I. Suppression of cerebral vasodilation with endothelin-1. Peptides 16: 1127-1132, 1995.
143. Kamouchi M, Kitazono T, Ago T, Wakisaka M, Ooboshi H, Ibayashi S, Iida M. Calcium influx pathways in rat CNS pericytes. Mol Brain Res 126: 114-120, 2004.
144. Kazama K, Anrather J, Zhou P, Girouard H, Frys K, Milner TA, Iadecola C. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res 95: 1019-1026, 2004.
145. Keen HL, Halabi CM, Beyer AM, de Lange WJ, Liu X, Maeda N, Faraci FM, Casavant TL, Sigmund CD. Bioinformatic analysis of gene sets regulated by ligand-activated and dominant-negative PPARγ in mouse aorta. Arterioscler Thromb Vasc Biol 30: 518-525, 2010.
146. Ketsawatsomkron P, Pelham CJ, Groh S, Keen HL, Faraci FM, Sigmund CD. Does peroxisome proliferator-activated receptor γ (PPARγ) protect from hypertension directly through effects in the vasculature? J Biol Chem 285: 9311-9316, 2010.
147. Khan SA, Nanduri J, Yuan G, Kinsman B, Kumar GK, Joseph J, Kalyanaraman B, Prabhakar NR. NADPH oxidase 2 mediates intermittent hypoxia-induced mitochondrial complex I inhibition: relevance to blood pressure changes in rats. Antioxid Redox Signal 14: 533-542, 2011.
148. Kidoguchi K, Tamaki M, Mizobe T, Koyama J, Kondoh T, Kohmura E, Sakurai T, Yokono K, Umetani K. In vivo X-ray angiography in the mouse brain using synchrotron radiation. Stroke 37: 1856-1861, 2006.
149. Kielstein JT, Donnerstag F, Gasper S, Menne J, Kielstein A, Martens- Lobenhoffer J, Scalera F, Cooke JP, Fliser D, Bode-Boger SM. ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 37: 2024-2029, 2006.
150. Kitayama J, Faraci FM, Gunnett CA, Heistad DD. Impairment of dilator responses of cerebral arterioles during diabetes mellitus: role of inducible NO synthase. Stroke 37: 2129-2133, 2006.
151. Kitayama J, Faraci FM, Lentz SR, Heistad DD. Cerebral vascular dysfunction during hypercholesterolemia. Stroke 38: 2136-2141, 2007.
152. Kitazono T, Heistad DD, Faraci FM. Dilatation of the basilar artery in response to selective activation of endothelin B receptors in vivo. J Pharmacol Exp Ther 273: 1-6, 1995.
153. Koedel U, Paul R, Winkler F, Kastenbauer S, Huang PL, Pfister HW. Lack of endothelial nitric oxide synthase aggravates murine pneumococcal meningitis. J Neuropathol Exp Neurol 60: 1041-1050, 2001.
154. Kohan DE, Rossi NF, Inscho EW, Pollock DM. Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev 91: 1-77, 2011.
155. Kondo T, Reaume AG, Huang TT, Carlson E, Murakami K, Chen SF, Hoffman EK, Scott RW, Epstein CJ, Chan PH. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci 17: 4180-4189, 1997.
156. Kontos HA. Role of products of univalent reduction of oxygen in hypertensive vascular injury. In: Hypertension: Pathophysiology, Diagnosis, and Management, edited by Laragh JH, Brenner BM. New York: Raven, 1990, chapt. 44, p. 667-675.
157. Kontos HA, Wei EP. Endothelium-dependent responses after experimental brain injury. J Neurotrauma 9: 349-354, 1992.
158. Kumai Y, Ooboshi H, Ago T, Ishikawa E, Takada J, Kamouchi M, Kitazono T, Ibayashi S, Iida M. Protective effect of angiotensin II type 1 receptor blocker on cerebral circulation independent of blood pressure. Exp Neurol 210: 441-448, 2008.
159. Lacza Z, Puskar M, Kis B, Perciaccante JV, Miller AW, Busija DW. Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin. Am J Physiol Heart Circ Physiol 283: H406-H411, 2002.
160. Lamping KG, Faraci FM. Role of sex differences and effects of endothelial NO synthase deficiency in responses of carotid arteries to serotonin. Arterioscler Thromb Vasc Biol 21: 523-528, 2001.
161. Lazarov O, Mattson MP, Peterson DA, Pimplikar SW, van Praag H. When neurogenesis encounters aging and disease. Trends Neurosci 33: 569-579, 2010.
162. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An anti-diabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma. J Biol Chem 270: 12953-12956, 1995.
163. Leiper JM, Vallance P. The synthesis and metabolism of asymmetric dimethylarginine (ADMA). Eur J Clin Pharmacol 62, Suppl 13: 33-38, 2006.
164. Leopold JA, Loscalzo J. Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med 47: 1673-1706, 2009.
165. Liang L, Tam CW, Pozsgai G, Siow R, Clark N, Keeble J, Husmann K, Born W, Fischer JA, Poston R, Shah A, Brain SD. Protection of angiotensin II-induced vascular hypertrophy in vascular smooth muscletargeted receptor activity-modifying protein 2 transgenic mice. Hypertension 54: 1254-1261, 2009.
166. Limbourg FP, Huang Z, Plumier JC, Simoncini T, Fujioka M, Tuckermann J, Schutz G, Moskowitz MA, Liao JK. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest 110: 1729-1738, 2002.
167. Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106: 987-992, 2002.
168. Liu J, Shimosawa T, Matsui H, Meng F, Supowit SC, DiPette DJ, Ando K, Fujita T. Adrenomedullin inhibits angiotensin II-induced oxidative stress via Csk-mediated inhibition of Src activity. Am J Physiol Heart Circ Physiol 292: H1714-H1721, 2007.
169. Lo EH, Hara H, Rogowska J, Trocha M, Pierce AR, Huang PL, Fishman MC, Wolf GL, Moskowitz MA. Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression. Stroke 27: 1381-1385, 1996.
170. Loirand G, Pacuad P. The role of Rho protein signaling in hypertension. Nat Rev Cardiol 7:637-647, 2010.
171. Loot AE, Schreiber JG, Fisslthaler B, Fleming I. Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase. J Exp Med 206: 2889-2896, 2009.
172. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115: 459-467, 2007.
173. Lubos E, Loscalzo J, Handy DE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal (November 18, 2010). doi:10.1089/ars.2010.3586.
174. Lund DD, Brooks RM, Faraci FM, Heistad DD. Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice. Am J Physiol Heart Circ Physiol 293: H3726-H3731, 2007.
175. MacKenzie A. Endothelium-derived vasoactive agents, AT1 receptors and inflammation. Pharmacol Ther (November 27, 2010). doi:10.1016/ j.pharmthera.2010.11.001.
176. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A. Protective role of interleukin-10 in atherosclerosis. Circ Res 85: e17-e24, 1999.
177. Manabe K, Shirahase H, Usui H, Kurahasi K, Fujiwara M. Endothelium- dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery. J Pharmacol Exp Ther 251: 317-320, 1989.
178. Maneen MJ, Cipolla MJ. Peroxynitrite diminishes myogenic tone in cerebral arteries: role of nitrotyrosine and F-actin. Stroke 37: 894-899, 2006.
179. Maneen MJ, Hannah R, Vitullo L, DeLance N, Cipolla MJ. Peroxynitrite diminishes myogenic activity and is associated with decreased vascular smooth muscle F-actin in rat posterior cerebral arteries. Am J Physiol Heart Circ Physiol 292: H1042-H1050, 2007.
180. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci 29: 367-374, 2008.
181. Marshall RS, Lazar RM. Pumps, aqueducts, and drought management. Vascular physiology in vascular cognitive impairment. Stroke 42: 221-226, 2011.
182. Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J. PPAR gamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPAR gamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol 19: 546-551, 1999.
183. Matsumoto T, Kobayahi T, Wachi H, Seyama Y, Kamata K. Vascular NAD(P)H oxidase mediates endothelial dysfunction in basilar arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Atherosclerosis 192: 15-24, 2007.
184. Mayhan WG. Role of prostaglandin H2-thromboxane A2 in responses of cerebral arterioles during chronic hypertension. Am J Physiol Heart Circ Physiol 262: H539-H543, 1992.
185. Mayhan WG. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol Cell Physiol 276: C1148-C1153, 1999.
186. Mayhan WG, Arrick DM, Sharpe GM, Sun H. Nitric oxide synthasedependent responses of the basilar artery during acute infusion of nicotine. Nicotine Tob Res 11: 270-2277, 2009.
187. Mayhan WG, Arrick DM, Sharpe GM, Sun H. Age-related alterations in reactivity of cerebral arterioles: role of oxidative stress. Microcirculation 15: 225-236, 2008.
188. Mayhan WG, Faraci FM, Baumbach GL, Heistad DD. Effects of aging on response of cerebral arterioles. Am J Physiol Heart Circ Physiol 258: H1138-H1143, 1990.
189. Mayhan WG, Faraci FM, Heistad DD. Impairment of endotheliumdependent responses of cerebral arterioles in chronic hypertension. Am J Physiol Heart Circ Physiol 253: H1435-H1440, 1987.
190. Mayhan WG, Faraci FM, Heistad DD. Mechanisms of protection of the blood-brain barrier during acute hypertension in chronically hypertensive rats. Hypertension 9: III101-III105, 1987.
191. Mayhan WG, Faraci FM, Heistad DD. Responses of cerebral arterioles to adenosine 5=-diphosphate, serotonin, and the thromboxane analogue U-46619 during chronic hypertension. Hypertension 12: 556-561, 1988.
192. Mayhan WG, Heistad DD. Role of veins and cerebral venous pressure in disruption of the blood-brain barrier. Circ Res 59: 216-220, 1986.
193. K+ in endothelium- derived hyperpolarizing factor-linked dilatation in rat middle cerebral artery. Stroke 36: 1526-1532, 2005.
194. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-C97, 2007.
195. Meredith D, Panchatcharam M, Miriyala S, Tsai YS, Morris AJ, Maeda N, Stouffer GA, Smyth SS. Dominant-negative loss of PPARγ function enhances smooth muscle cell proliferation, migration, and vascular remodeling. Arterioscler Thromb Vasc Biol 29: 465-471, 2009.
196. Miller AA, De Silva TM, Judkins CP, Drummond GR, Sobey CG. Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia. Stroke 41: 784-789, 2010.
197. Miller AA, Drummond GR, Schmidt HHHW, Sobey CG. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res 97: 1055-1062, 2005.
198. Modrick ML, Didion SP, Lynch CM, Dayal S, Lentz SR, Faraci FM. Role of hydrogen peroxide and the impact of glutathione peroxidase-1 in regulation of cerebral vascular tone. J Cereb Blood Flow Metab 29: 1130-1137, 2009.
199. Modrick ML, Didion SP, Sigmund CD, Faraci FM. Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging. Am J Physiol Heart Circ Physiol 296: H1914-H1919, 2009.
200. Montezano AC, Burger D, Ceravolo GS, Yusaf H, Montero M, Touyz RM. Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5. Clin Sci (Lond) 120: 131-141, 2011.
201. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 67: 181-198, 2010.
202. Mulvany MJ. Small artery structure: time to take note? Am J Hypertens 20: 853-854, 2007.
203. Munzel T, Gori T, Bruno RM, Taddei S. Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 31: 2741-2749, 2010.
204. Murphy S, Rich G, Orgren KI, Moore SA, Faraci FM. Astrocytederived lipoxygenase product evokes endothelium-dependent relaxation of the basilar artery. J Neurosci Res 38: 314-318, 1994.
205. Nag S, Kapadia A, Stewart DJ. Molecular pathogenesis of blood-brain barrier breakdown in acute brain injury. Neuropathol Appl Neurobiol 37: 3-23, 2011.
206. Nakamura T, Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, Ogawa H, Kim-Mitsuyama S. Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure. Stroke 38: 3016-3022, 2007.
207. Nelson CW, Wei EP, Povlishock JT, Kontos HA, Moskowitz MA. Oxygen radicals in cerebral ischemia. Am J Physiol Heart Circ Physiol 263: H1356-H1362, 1992.
208. Ngai AC, Winn HR. Modulation of cerebral arteriolar diameter by intraluminal flow and pressure. Circ Res 77: 832-840, 1995.
209. Nicolakakis N, Aboulkassim T, Aliaga A, Tong XK, Rosa-Neto P, Hamel E. Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone. J Cereb Blood Flow Metab 31: 200-211, 2011.
210. Nicolakakis N, Aboulkassim T, Ongali B, Lecrux C, Fernandes P, Rosa-Neto P, Tong XK, Hamel E. Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist. J Neurosci 28: 9287-9296, 2008.
211. Nishimura Y, Ito T, Saavedra JM. Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31: 2478-2486, 2000.
212. Nunes KP, Rigsby CS, Webb RC. RhoA/rho-kinase and vascular diseases: what is the link? Cell Mol Life Sci 67: 3823-3836, 2010.
213. Ogawa K, Tokinaga Y, Iwahashi S, Mizumoto K, Hatano Y. Halothane does not protect against vascular injury in isolated cerebral and mesenteric arteries. Can J Anaesth 52: 870-877, 2005.
214. Ohashi M, Runge MS, Faraci FM, Heistad DD. MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 26: 2331-2336, 2006.
215. Oldendorf WH, Cornford ME, Brown WJ. The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol 1: 409-417, 1977.
216. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340: 14-22, 1999.
217. Onoue H, Katusic ZS. The effect of 1H-[1, 2, 4]oxadiazolo[4, 3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide. Brain Res 785: 107-113, 1998.
218. Onoue H, Tsutsui M, Smith L, Stelter A, O'Brien T, Katusic ZS. Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 29: 1959-1966, 1998.
219. Paravicini TM, Miller AA, Drummond GR, Sobey CG. Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol-3 kinase, NADPH oxidase, and nitric oxide synthase. J Cereb Blood Flow Metab 26: 836-845, 2006.
220. Park L, Anrather J, Girouard H, Zhou P, Iadecola C. Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J Cereb Blood Flow Metab 27: 1908-1918, 2007.
221. Park L, Anrather J, Zhou P, Frys K, Pitstick R, Younkin S, Carlson GA, Iadecola C. NADPH oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid β peptide. J Neurosci 25: 1769-1777, 2005.
222. Park L, Zhou P, Pitstick R, Capone C, Anrather J, Norris EH, Younkin L, Younkin S, Carlson G, McEwen BS, Iadecola C. Nox2- derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad Sci USA 105: 1347-1352, 2008.
223. Peraza M, Burdick AD, Marin HE, Gonzalez FJ, Peters JM. The toxicology of ligands for peroxisome proliferator-activator receptors (PPAR). Toxicol Sci 90: 269-295, 2006.
224. Phillips SA, Olson EB, Morgan BJ, Lombard JH. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286: H388-H393, 2004.
225. Phillips SA, Sylvester FA, Frisbee JC. Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288: R522-R530, 2005.
226. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fisher JA, Foord SM. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233-246, 2002.
227. Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 451: 904-913, 2008.
228. Raines EW, Garton KJ, Ferri N. Beyond the endothelium: NF-κB regulation of smooth muscle function. Circ Res 94: 706-708, 2004.
229. Ramirez SH, Heilman D, Morsey B, Potula R, Haorah J, Persidsky Y. Activation of peroxisome proliferator-activated receptor gamma (PPAR gamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes. J Immunol 180: 1854-1865, 2008.
230. Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensininduced hypertension. Am J Physiol Regul Integr Comp Physiol 284: R893-R912, 2003.
231. Rizzoni D, De Ciuceis C, Porteri E, Paiardi S, Boari GEM, Mortini P, Cornali C, Cenzato M, Rodella LF, Borsani E, Rizzardi N, Platto C, Rezzani R, Rosei EA. Altered structure of small cerebral arteries in patients with essential hypertension. J Hypertens 27: 838-845, 2009.
232. Roberts TJ, Chapman AC, Cipolla MJ. PPAR-gamma agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension. Am J Physiol Heart Circ Physiol 297: H1347-H1353, 2009.
233. Rodionov RN, Dayoub H, Lynch CM, Wilson KM, Stevens JW, Murry DJ, Kimoto M, Arning E, Bottiglieri T, Cooke JP, Baumbach GL, Faraci FM, Lentz SR. Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. Circ Res 106: 551-558, 2010.
234. Roman GC, Kalaria RN. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging 27: 1769-1785, 2006.
235. Roszer T, Ricote M. PPARs in the renal regulation of systemic blood pressure. PPAR Res 2010: 698730, 2010.
236. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101: 731-736, 1998.
237. Rush JWE, Turk JR, Laughlin MH. Exercise training regulates SOD-1 and oxidative stress in porcine aortic endothelium. Am J Physiol Heart Circ Physiol 284: H1378-H1387, 2003.
238. Ryan MJ, Didion SP, Mathur S, Faraci FM, Sigmund CD. Angiotensin II-induced vascular dysfunction is mediated by the AT1A receptor in mice. Hypertension 43: 1074-1079, 2004.
239. Ryan MJ, Didion SP, Mathur S, Faraci FM, Sigmund CD. The PPARγ agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension 43: 661-666, 2004.
240. Saavedra JM, Sanchez-Lemus E, Benicky J. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology 36: 1-18, 2011.
241. Santhanam AVR, Smith LA, Nath KA, Katusic ZS. In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries. Am J Physiol Heart Circ Physiol 291: H781-H786, 2006.
242. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275: 21722-21729, 2000.
243. Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond) 112: 375-384, 2007.
244. Scalera F, Martens-Lobenhoffer J, Bukowska A, Lendeckel U, Tager M, Bode-Boger SM. Effect of telmisartan on nitric oxide-asymmetrical dimethylarginine system. Role of angiotensin II type 1 receptor and peroxisome proliferator activated receptor γ signaling during endothelial aging. Hypertension 51: 696-703, 2008.
245. Scalera F, Borlak J, Beckmann B, Martens-Lobenhoffer J, Thum T, Tager M, Bode-Boger SM. Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence. Arterioscler Thromb Vasc Biol 24: 1816-1822, 2004.
246. Schaeffer C, Vandroux D, Thomassin L, Athias P, Rochette L, Connat JL. Calcitonin gene-related peptide partly protects cultured smooth muscle cells from apoptosis induced by an oxidative stress via activation of ERK1/2 MAPK. Biochim Biophys Acta 1643: 65-73, 2003.
247. Schmidt MV, Bernhard B, Von Knethen A. The nuclear hormone receptor PPAR as a therapeutic target in major diseases. Scientific- WorldJournal 10: 2181-2197, 2010.
248. Schoonman GG, Van der Grond J, Kortmann C, Van der Geest RJ, Terwindt GM, Ferrari MD. Migraine headache is not associated with cerebral or meningeal vasodilatation-a 3T magnetic resonance angiography study. Brain 131: 2192-2200, 2008.
249. Schrader LI, Kinzenbaw DA, Johnson AW, Faraci FM, Didion SP. IL-6 deficiency protects against angiotensin II-induced endothelial dysfunction and hypertrophy. Arterioscler Thromb Vasc Biol 27: 2576-2581, 2007.
250. Schreibelt G, Kooij G, Reijerkerk A, Van Doorn R, Gringhuis SI, Van der Pol S, Weksler BB, Romera IA, Courand PO, Piontek J, Blasig IE, Dijkstra CD, Ronken E, de Vries HE. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 21: 3666-3676, 2007.
251. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, Vincent P, Pumiglia K, Temple S. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304: 1338-1340, 2004.
252. Sigmund CD. Endothelial and vascular muscle PPARγ in arterial pressure regulation. Lessons from genetic interference and deficiency. Hypertension 55: 437-444, 2010.
253. Sobey CG, Cocks TM. Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo. Stroke 29: 1439-1444, 1998.
254. Sobey CG, Faraci FM. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Stroke 28: 837-843, 1997.
255. Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY, Kumar A, Meurer S, Deile M, Taye A, Knorr A, Lapp H, Muller H, Turgay Y, Rothkegel C, Tersteegan A, Kemp-Harper B, Muller-Esterl W, Schmidt HHHW. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest 116: 2552-2561, 2006.
256. Stenman E, Edvinsson L. Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 35: 970-974, 2004.
257. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381-1478, 2004.
258. Straub SV, Nelson MT. Astrocytic calcium signaling: the information currency coupling neuronal activity to the cerebral microcirculation. Trends Cardiovasc Med 17: 183-190, 2007.
259. Sugawara A, Takeuchi K, Uruno A, Ikeda Y, Arima S, Kudo M, Sato K, Taniyama Y, Ito S. Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor- gamma in vascular smooth muscle cells. Endocrinology 142: 3125-3134, 2001.
260. Sun H, Molacek E, Zheng H, Fang Q, Patel KP, Mayhan WG. Alcohol-induced impairment of neuronal nitric oxide synthase (nNOS)- dependent dilation of cerebral arterioles: role of NAD(P)H oxidase. J Mol Cell Cardiol 40: 321-328, 2006.
261. Sun H, Patel KP, Mayhan WG. Tetrahydrobiopterin, a cofactor for NOS, improves endothelial dysfunction during chronic alcohol consumption. Am J Physiol Heart Circ Physiol 281: H1863-H1869, 2001.
262. Sun H, Zheng H, Molacek E, Fang Q, Patel KP, Mayhan WG. Role of NAD(P)H oxidase in alcohol-induced impairment of endothelial nitric oxide synthase-dependent dilation of cerebral arterioles. Stroke 37: 495-500, 2006.
263. Sylvester FA, Stepp DW, Frisbee JC, Lombard JH. High-salt diet depresses acetylcholine reactivity proximal to NOS activation in cerebral arteries. Am J Physiol Heart Circ Physiol 283: H353-H363, 2002.
264. Taguchi H, Faraci FM, Kitazono T, Heistad DD. Relaxation of the carotid artery during hypoxia is impaired in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 15: 1641-1645, 1995.
265. Takahashi N, Smithies O. Human genetics, animal models and computer simulations for studying hypertension. Trends Genet 20: 136-145, 2004.
266. Takeda S, Sato N, Takeuchi D, Kurinami H, Shinohara M, Niisato K, Kano M, Ogihara T, Rakugi H, Morishita R. Angiotensin receptor blocker prevented β-amyloid induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension 54: 1345-1352, 2009.
267. Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res 88: 877-887, 2001.
268. Thompson PW, Bayliffe Warren AP, Lamb JR. Interleukin-10 is upregulated by nanomolar rosiglitazone treatment of mature dendritic cells and human CD4+ T cells. Cytokine 39: 184-191, 2007.
269. Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev 61: 62-97, 2009.
270. Trauernicht AK, Sun H, Patel KP, Mayhan WG. Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats. Stroke 34: 2698-2703, 2003.
271. Tsai YS, Kim HJ, Takahashi N, Kim HS, Hagaman JR, Kim JK, Maeda N. Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ. J Clin Invest 114: 240-249, 2004.
272. Ujiie H, Chaytor AT, Bakker LM, Griffith TM. Essential role of gap junctions in NO- and prostanoid-independent relaxations evoked by acetylcholine in rabbit intracerebral arteries. Stroke 34: 544-550, 2003.
273. Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24: 1023-1030, 2004.
274. Vanhoutte PM, Shimokawa J, Tang EHC, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196: 193-222, 2009.
275. Virdis A, Ghiadoni L, Taddei S. Human endothelial dysfunction: EDCFs. Pflügers Arch 459: 1015-1023, 2010.
276. Volpe M, Iaccarino G, Cecchione C, Rizzoni D, Russo R, Rubattu S, Condorelli G, Ganten U, Ganten D, Trimarco B, Lindpainter K. Association and cosegregation of stroke with impaired endotheliumdependent vasorelaxation in stroke prone, spontaneously hypertensive rats. J Clin Invest 98: 256-261, 1996.
277. Wang YX. PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res 20: 124-137, 2010.
278. Wassman S, Nickenig G. Pathophysiological regulation of the AT1- receptor and implications for vascular disease. J Hypertens 24, Suppl 1: S15-S21, 2006.
279. Wassman S, Wassmann K, Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44: 381-386, 2004.
280. Wei EP, Kontos HA, Christman CW, DeWitt DS, Povlishock JT. Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilation after acute hypertension. Circ Res 57: 781-787, 1985.
281. Widlandsky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42: 1149-1160, 2003.
282. Widlansky ME, Gutterman DD. Regulation of endothelial function by mitochondrial reactive oxygen species. Antioxid Redox Signal (January 2, 2011). doi:10.1089/ars.2010.3642.
283. Wood KC, Hebbel RP, Granger DN. Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice. FASEB J 19: 989-991, 2005.
284. Wosniak J, Santos CXC, Kowaltowski AJ, Laurindo FRM. Crosstalk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells. Antioxid Redox Signal 11: 1265-1278, 2009.
285. Wu JS, Cheung WM, Tsai YS, Chen YT, Fong WH, Tsai HD, Chen YC, Liou JY, Shyue SK, Chen JJ, Chen YE, Maeda N, Wu KK, Lin TN. Ligand-activated peroxisome proliferator-activated receptor-γ protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3e upregulation. Circulation 119: 1124-1134, 2009.
286. Xie H, Ray PE, Short BL. NF-κB activation plays a role in superoxidemediated cerebral endothelial dysfunction after hypoxia/reoxygenation. Stroke 36: 1047-1052, 2005.
287. Yamashiro K, Milsom AB, Duchene J, Panayiotou C, Urabe T, Hattori N, Ahluwalia A. Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice. J Cereb Blood Flow Metab 30: 1494-1503, 2010.
288. Yang ST, Faraci FM, Heistad DD. Effects of cilazapril on cerebral vasodilatation in hypertensive rats. Hypertension 22: 150-155, 1993.
289. Yang X, Wang F, Chang H, Zhang S, Yang L, Wang X, Cheng X, Zhang M, Ma XL, Liu H. Autoantibody against AT1 receptor from preelamptic patients induces vasoconstriction through angiotensin receptor activation. J Hypertens 26: 1629-1635, 2008.
290. Yoshimoto T, Gochou N, Fukai N, Sugiyama T, Shichiri M, Hirata Y. Adrenomedullin inhibits angiotensin II-induced oxidative stress and gene expression in rat endothelial cells. Hypertens Res 28: 165-172, 2005.
291. You J, Johnson TD, Marrelli SP, Bryan RM Jr. Functional heterogeneity of endothelial P2 purinoceptors in the cerebrovascular tree of the rat. Am J Physiol Heart Circ Physiol 277: H893-H900, 1999.
292. Zanetti M, Dato J'I, Katusic ZS, O'Brien T. Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. Am J Physiol Heart Circ Physiol 280: H2516-H2523, 2001.
293. Zemse SM, Hilgers RH, Webb RC. Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings. Am J Physiol Heart Circ Physiol 292: H3103-H3108, 2007.
294. Zhang JY, Cao YX, Xu CB, Edvinsson L. Lipid-soluble smoke particles damage endothelial cells and reduce endothelium-dependent dilatation in rat and man. BMC Cardiovasc Disord 6: 3, 2006.
295. Zhang F, Xu S, Iadecola C. Role of nitric oxide and acetylcholine in neocortical hyperemia elicited by basal forebrain stimulation: evidence for an involvement of endothelial nitric oxide. Neuroscience 69: 1195-1204, 1995.
296. Zhang M, Mao Y, Ramirez SH, Tuma RF, Chabrashvili T. Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience 171: 852-858, 2010.
297. Zhang M, Song P, Xu J, Zou MH. Activation of NAD(P)H oxidases by thromboxane A2 receptor uncouples endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol 31: 125-132, 2011.
298. Zhang R, Bai YG, Lin LJ, Bao JX, Zhang YY, Tang H, Cheng JH, Jia GL, Ren XL, Ma J. Blockade of AT1 receptor partially restores vasoreactivity, NOS expression, and superoxide levels in cerebral and carotid arteries of hindlimb unweighting rats. J Appl Physiol 106: 251-258, 2009.
299. Zhang R, Wang L, Zhang L, Chen J, Zhu Z, Zhang Z, Chopp M. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ Res 92: 308-313, 2003.
300. Zhou A, Carrell RW, Murphy MP, Wei Z, Yan Y, Stanley PLD, Stein PE, Pipkin FB, Read RJ. A redox switch in angiotensinogen modulates angiotensin release. Nature 468: 108-111, 2010.